![]() ![]() On September 22, 2014, Merck KGaA, Darmstadt, Germany and Sigma-Aldrich announced that they entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck will continue to closely cooperate with the relevant antitrust authorities. The closing remains subject to certain other conditions, including remaining antitrust clearances from Brazil’s Council for Economic Defense (CADE) as well as from the competition authorities of Israel (IAA) and Korea (KFTC). The commitments also include the transfer of customer information and a solution to ensure a temporary channel to the market.īased on the recent clearances, Merck KGaA, Darmstadt, Germany said it will continue to work toward a mid-2015 completion of the transaction as detailed on the occasion of Merck KGaA, Darmstadt, Germany’s first-quarter earnings release on May 19, 2015. In addition, the divestiture of solvents and inorganics sold by Sigma-Aldrich worldwide under the Fluka, Riedel-de-Haen and Hydranal brands as well as a temporary license to the Sigma-Aldrich brand for the supply of solvents and inorganics in the European Economic Area have been agreed. These include its manufacturing assets in Seelze, Germany, where most of the solvents and inorganics sold by Sigma-Aldrich in Europe are manufactured. We will work closely with employee representatives to ensure that our values as a responsible employer are reflected throughout the process.”Īs part of the EU commitments, Merck KGaA, Darmstadt, Germany and Sigma-Aldrich have agreed to sell parts of Sigma-Aldrich’s solvents and inorganics business in Europe. ![]() As always, we are committed to ensuring a smooth transition for both customers and employees. “We will now work with all related parties in the coming months to swiftly implement the commitments that have been agreed with the EU. ![]() “Those approvals are very important as we’re working toward completing the acquisition of Sigma-Aldrich, and we remain excited about the transformational opportunities this acquisition will create for our company in life science,” said Bernd Reckmann, Member of the Executive Board of Merck KGaA, Darmstadt, Germany. In addition, Merck KGaA, Darmstadt, Germany has already secured antitrust clearance from the U.S., Taiwan, South Africa, Russia, Serbia and Ukraine. The EU clearance, which is subject to certain conditions, follows the recent antitrust approvals in Japan (JFTC) and by the Chinese Ministry of Commerce (MOFCOM). Merck KGaA (Germany) has announced that the European Commission has approved its planned acquisition of U.S.-based life science company Sigma-Aldrich. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |